Perflutren Patent Expiration
Perflutren is used for medical imaging using ultrasound technology. It was first introduced by Lantheus Medical Imaging Inc
Perflutren Patents
Given below is the list of patents protecting Perflutren, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Definity | US10588988 | Methods and devices for preparation of ultrasound contrast agents | May 04, 2037 | Lantheus Medcl |
| Definity Rt | US10588988 | Methods and devices for preparation of ultrasound contrast agents | May 04, 2037 | Lantheus Medcl |
| Definity | US10583208 | Methods for making ultrasound contrast agents | Mar 16, 2037 | Lantheus Medcl |
| Definity | US11266750 | Methods for making ultrasound contrast agents | Mar 16, 2037 | Lantheus Medcl |
| Definity | US11529431 | Methods for making ultrasound contrast agents | Mar 16, 2037 | Lantheus Medcl |
| Definity | US11857646 | Methods for making ultrasound contrast agents | Mar 16, 2037 | Lantheus Medcl |
| Definity | US11925695 | Methods for making ultrasound contrast agents | Mar 16, 2037 | Lantheus Medcl |
| Definity | US9789210 | Methods for making ultrasound contrast agents | Mar 16, 2037 | Lantheus Medcl |
| Definity Rt | US10583208 | Methods for making ultrasound contrast agents | Mar 16, 2037 | Lantheus Medcl |
| Definity Rt | US11266750 | Methods for making ultrasound contrast agents | Mar 16, 2037 | Lantheus Medcl |
| Definity Rt | US11529431 | Methods for making ultrasound contrast agents | Mar 16, 2037 | Lantheus Medcl |
| Definity Rt | US11857646 | Methods for making ultrasound contrast agents | Mar 16, 2037 | Lantheus Medcl |
| Definity Rt | US11925695 | Methods for making ultrasound contrast agents | Mar 16, 2037 | Lantheus Medcl |
| Definity Rt | US9789210 | Methods for making ultrasound contrast agents | Mar 16, 2037 | Lantheus Medcl |
| Definity | US10583207 | Lipid-encapsulated gas microsphere compositions and related methods | Dec 28, 2035 | Lantheus Medcl |
| Definity Rt | US10022460 | Lipid-encapsulated gas microsphere compositions and related methods | Dec 28, 2035 | Lantheus Medcl |
| Definity Rt | US10583207 | Lipid-encapsulated gas microsphere compositions and related methods | Dec 28, 2035 | Lantheus Medcl |
| Definity Rt | US11395856 | Lipid-encapsulated gas microsphere compositions and related methods | Dec 28, 2035 | Lantheus Medcl |
| Definity | US8658205 | Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
Jun 18, 2019
(Expired) | Lantheus Medcl |
| Definity | US8685441 | Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
Jan 13, 2019
(Expired) | Lantheus Medcl |
| Definity | US9545457 | Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
Jan 13, 2019
(Expired) | Lantheus Medcl |
| Definity | US6033645 | Methods for diagnostic imaging by regulating the administration rate of a contrast agent |
Jun 19, 2016
(Expired) | Lantheus Medcl |
| Definity | US5527521 | Low density microspheres and suspensions and their use as contrast agents for computed tomography and in other applications |
Feb 22, 2015
(Expired) | Lantheus Medcl |
| Definity | US5585112 | Method of preparing gas and gaseous precursor-filled microspheres |
Dec 17, 2013
(Expired) | Lantheus Medcl |
Perflutren's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List